MindWalk Holdings (HYFT) Net Income (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Net Income came in at -$2.5 million in Q2 2026, down 264.34% year-over-year from $1.5 million in Q2 2025, and down 188.13% quarter-over-quarter from $2.8 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Net Income (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Net Income for 7 consecutive years, with -$2.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income fell 264.34% year-over-year to -$2.5 million in Q2 2026; TTM through Apr 2026 was $4.8 million, a 77.87% decrease from a year earlier, with the FY2026 full-year figure at -$1.0 million, down 104.8% from the prior year.
- Net Income was -$2.5 million for Q2 2026 at MindWalk Holdings, down from $2.8 million in the prior quarter.
- Over five years, Net Income peaked at $15.2 million in Q1 2025 and troughed at -$7.5 million in Q3 2022.
- A 5-year average of $1.4 million and a median of $1.8 million in 2024 frame the typical range for Net Income.
- Across the five-year window, Net Income soared 665.28% in 2025 and tumbled 264.34% in 2026, its largest moves.
- Over 5 years, Net Income stood at -$5.5 million in 2022, then surged by 132.13% to $1.8 million in 2023, then advanced by 5.14% to $1.9 million in 2024, then surged by 251.39% to $6.6 million in 2025, then slumped by 137.99% to -$2.5 million in 2026.
- The last three Net Income figures came in at -$2.5 million (Q2 2026), $2.8 million (Q1 2026), and $6.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 241.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -760,000.00 |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 111.81 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -46.71 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -667,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -2.50 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -2.50 Mn |
| Jan 31, 2026 | 2.83 Mn |
| Oct 31, 2025 | 6.57 Mn |
| Jul 31, 2025 | -2.15 Mn |
| Apr 30, 2025 | 1.52 Mn |
| Jan 31, 2025 | 15.16 Mn |
| Oct 31, 2024 | 1.87 Mn |
| Jul 31, 2024 | 2.92 Mn |
| Apr 30, 2024 | 12.99 Mn |
| Jan 31, 2024 | 1.98 Mn |
| Oct 31, 2023 | 1.78 Mn |
| Jul 31, 2023 | 2.56 Mn |
| Apr 30, 2023 | 3.79 Mn |
| Jan 31, 2023 | -3.32 Mn |
| Oct 31, 2022 | -5.53 Mn |
| Jul 31, 2022 | -7.52 Mn |
| Apr 30, 2022 | -4.19 Mn |
| Jan 31, 2022 | -3.57 Mn |
| Oct 31, 2021 | -3.88 Mn |
| Jul 31, 2021 | -2.97 Mn |